Stay updated on Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.

Latest updates to the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a backend version update with no user-facing changes.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedMinor version update noted: v3.4.2 has been added and v3.4.1 removed. This appears to be a maintenance change rather than a change to study data or user actions.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no visible changes to study details or page layout are observed.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page footer now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check108 days agoChange DetectedPublication source description changed from 'These publications come from PubMed... automatically created by ClinicalTrials.gov Identifier (NCT Number)' to 'These publications are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study', and the revision tag updated from v3.2.0 to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.